Objective: Functional data analysis (FDA) is a forecasting approach that, to date, has not been applied to obesity, and that may provide more accurate forecasting analysis to manage uncertainty in public health. This paper uses FDA to provide projections of Body Mass Index (BMI), overweight and obesity in an Australian population through to 2019.
T he rapid rise in obesity has been well documented internationally. 1, 2 For example, the US has maintained an historical record of the rise in obesity through its National Health and Nutrition Examination Survey (NHANES) series. In the 1960s, the prevalence of overweight and obesity was about 45% and it has steadily increased to a point where now the latest figures suggest almost three-quarters of American adults are overweight or obese 3, 4 and 35% are obese. 5 Population monitoring in other industrialised countries, including Australia, France and the UK, has also tracked this rise, albeit at a lower prevalence than the US. [6] [7] [8] Australia's monitoring in nationally representative samples has been sporadic, but shows overweight and obesity has increased from 56.3% in 1995 to 62.8% in 2011-12. As a subset, the proportion of Australians who are obese has increased from 18.7% to 27.5%. 9 Projection analysis undertaken as part of the OECD Economics of Prevention (2009) used national health survey data from 12 countries to estimate overweight and obesity prevalence for 2014 and forward to 2019. Generally, the results suggest stabilisation in rates of overweight, but continuing increases in obesity. The Australian projections used data from four national surveys (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) and the forecasted rates of overweight and obesity were estimated to be about 60% in 2014 and 65% in 2019. 1 However, recent national health survey data shows Australia has surpassed the 2014 projections and is fast approaching the estimated prevalence for 2019 -almost five years early. 9 Time series forecasting is used as a practical planning tool for governments to help manage future uncertainty, and to inform health policy change. It is most useful when it is based on quality data and uses robust statistical methods. Functional data analysis (FDA) is one such approach starting to receive attention in the literature, particularly in terms of its public health and biomedical applications, [10] [11] [12] but has yet to be applied to obesity. Commonly, time series data are treated as multivariate data because they are given as a discrete time series, and important information about the smooth functional behaviour of generating trend analysis tends to be ignored. FDA has the advantage of generating models that can be described by continuous smooth dynamics. It uses effective data noise reduction through curve smoothing techniques, which then allow for more accurate estimates of parameters for use in the forecasting analysis. This paper applies FDA to 10 years of population survey data to provide projections of overweight and obesity in South Australia forward to 2019. This outlook will allow comparison with other international projections provided by the OECD Economics of Prevention but will also be a useful time frame to facilitate government planning and policy development. The objectives are to describe the past trends and future projections (through to 2019) in body mass index, overweight and obesity prevalence rates in South Australia; and to identify particular age-gender subgroups of the population at higher risk of obesity.
Methods

Sample
Data were collected using the South Australian Monitoring and Surveillance System (SAMSS) from January 2003 to December 2012. The population of South Australia is about 1.5 million (in 2011), accounting for 7.5% of the total Australian population. 13 The SAMSS is a Computer Assisted Telephone Interview survey that monitors self-reported trends in risk factors, disease and other health service issues. Interviews are conducted on a minimum of 600 randomly selected people each month. All households in South Australia with a telephone connected and the telephone number listed in the Electronic White Pages are eligible for selection. A letter introducing the survey is sent to the selected household and the person with the last birthday within a 12-month period is chosen for interview. Interviews are conducted with people of all ages, using parent-proxies for children under 16 years of age. Up to 10 call backs were made to the household to interview the selected persons, with no replacements made for non-respondents. Interviews were conducted by trained health interviewers. To ensure the SAMSS data is representative, the data were weighted by age, gender and area (metropolitan/rural) of residence to reflect the structure of the South Australian population in the Australian Census and the probability of selection in the household. Weighting was corrected for disproportionality of the sample with respect to the population of interest. This weighting is based on a random selection of households and one person within the household. 14 The method is described in more detail elsewhere. 14 From January 2003 to December 2012, 65,557 interviews were conducted with participants from birth through to 102 years of age (participation rate 60-70%). This paper is limited to data collected from 51,618 adults (18 years and over). This represent all adult records in the survey (the expected total of 72,000, that is 600 per month over 10 years , includes children). The sample size ranged from 4,502 to 5,401 people per year, was 50.3% female overall, and had a relatively even distribution across the age groups (see Supplementary Table 1 , available with the online version of this article).
The interview questions of relevance to this paper included self-reported height and weight and personal details such as age and gender (Ethics approval number: HREC 479/11/2014).
Body Mass Index and weight status
BMI was calculated (in kg/m 2 ) and converted to weight status categories using the World Health Organization cut-offs. 15 Data were categorised into three weight status groups: underweight and healthy weight (BMI less than 25 kg/m 2 ); overweight (greater than or equal to 25 kg/m 2 and less than 30 kg/ m 2 ); and obese (greater than or equal to 30 kg/m 2 ). 15 Nine extreme BMI values (less than 13 kg/m 2 or greater than 97 kg/m 2 ) were excluded from the analysis based on cut-offs provided by the Australian Bureau of Statistics, consistent with those used in the recent National Health Survey 16 and personal communication.
The BMI data were normally distributed therefore mean and standard deviations were used to summarise the data. Percentages were used to describe the proportions of the population in each weight status category across age and gender. Past differences in BMI between groups at single time points were assessed using Analysis of Variance (ANOVA) with Bonferroni adjustments.
Forecasting framework -Functional Data Analysis
The FDA approach was applied to model and forecast average BMI, overweight and obesity prevalence rates. Generally, this approach involved four interrelated steps that can be summarised as follows: a) model the reported discrete data by smoothing technique and construct smooth continuous functional observations. This emphasises patterns in the data by minimising short-term deviations due to observational errors, such as measurement errors or inherent system noise; b) apply functional decomposition technique onto the smoothed functional observations to estimate the time-invariant basis functions and the associated time series coefficients. This decomposition is obtained by transforming the data to a new set of variables, or principal components that are uncorrelated and ordered so that the first few retain most of the variation present in all of the original dataset; c) a standard time series technique to model and forecast the time series coefficients; and d) combine the resulting time series forecasts with the time-invariant basis functions and generate forecasts of BMI, overweight and obesity for each year.
To implement these steps, following the convention in FDA, the observed average BMI or overweight and obesity prevalence rates for age x in year t, y t (x), are described as: y t (x)
is an independently and identically distributed standard normal random variable and σ t (x) allows the variance to change with age and year according to the nature of the data. The second equation Although a number of methods have been used, [17] [18] [19] [20] the age-gender BMIs for each year were smoothed using weighted regression splines 11 to estimate the age-BMI curves. Since the BMI increased rapidly up to a certain age and then declined, the BMI curves were assumed to concave with age. To capture the concave trends in BMI, constrained concavity 21 applied to smooth curves was used according to the method of Hyndman and Ullah. 11 The use of weighted regression splines has a number of advantages in that: a) the smoothness conditions can easily be adopted to the nature of the BMI data analysed, thereby reducing the noise in the BMI curves; and b) the underlying process generating the age-BMI curves is then continuous and smooth. Once the © 2015 Public Health Association of Australia required smoothed functions are generated, the resulting series were subsequently decomposed into an optimal number of orthogonal functional principal components (FPC) and their associated time series coefficients using the FPC technique. 11 As all parameters on the right-hand side of the second equation are unobservable, fitting the model using the ordinary least square method is impossible. To overcome this situation, FPC decomposition was applied to the smoothed BMI curves.
Finally, given that time series coefficients are uncorrelated, we generated forecast for each time series separately. To keep the forecasts within acceptable confidence bounds, we limited the forecast interval to 7 years or 28 quarters, and generated forecasts on BMI for each quarter from 2013-19. An exponential smoothing state space model selection algorithm 22, 23 was used for forecasting BMI time series coefficients. We combined the forecasted time series coefficients with their corresponding basis functions to obtain forecasts of BMI. All analyses were performed using R version 13.0. 24, 25 
Forecast accuracy
The accuracy of forecasts was evaluated by computing the integrated squared prediction error, ISPE n (h)= ∫ x e 2 n,h (x)dx where e n,h (x)=y n+h (x)-ŷ n+h (x) which denotes the prediction error. In designing the accuracy measures for the future age-specific BMI, an out-of-sample test was performed. 26 An out-of-sample evaluation of forecast accuracy begins with the division of the time series set into a fit period and a test period. The fit period is used to identify and estimate an appropriate model, based on a set of the observed data for that period and does not involve any predictions. The test period also uses observed data but this is compared to predictions arising from the model generated for the fit period and so measures the model's prediction accuracy. Based on the fitting period 2003-10, the FDA forecasts of BMI for 2011-12 were directly compared with the actual data for 2011-12 through averaging of the Integrated Squared Forecast Error (ISPE). 11 Table 1 shows the trends in BMI, by age and gender, over the period 2003-12. The average BMI of males has increased from 26.7kg/m 2 in 2003 to 27.2kg/m 2 in 2012 (p=0.009) and from 25.8kg/m 2 to 26.4kg/m 2 for females (p=0.007). Average BMI generally increased with age (p<0.001). In males, BMI peaked in the 45-54 year age group and females in the 55-64 year age groups, before decreasing in the older age groups. Over 10 years, South Australians aged 18-24 consistently reported the lowest BMI. With one exception -males in 2012the average BMI for this age group has been below 25 (Table 1 ). Figure 1 shows the results of the functional data analysis showing the past rate of change in BMI by age and gender (Figures 1b and 1e ) and the forecast coefficients for projecting future trends (Figures 1c and 1f ). The first basis function indicates that the rate of change in BMI from 2003-12 has differed by gender. Past trends show the greatest rate of increase has occurred in females aged 25-34 years (Figure 1b) . The peak in the basis function curve is more gradual and slightly lower in males than females, with the peak occurring over the 25-34 and 35-44 year age groups and dropping off more gradually with age than for females ( Figure 1e ). Based on these past trends, the forecast coefficients for males and females suggest a continuing positive increase in BMI through to 2019 (Figures 1c and 1f) . Figures 1a and 1d) , the first basis function (Figures 1b and 1e ) and the coefficient associated with the first basis function (Figures 1c and 1f) . suggest marked increases are expected in some age groups, particularly females around 30 years of age where an increase of more than 1kg/m 2 is expected by 2019 ( Figure 3a ).
Results
BMI
Figure 1: Principal components from the Functional Data Analysis (FDA) for male and female BMI: the mean BMI (
Overweight Figure 4a shows a notable disparity in the prevalence of overweight between males and females across all years from 2003 to 2012. In 2012, 45.6% of males were considered overweight and 27.9% of females. The increase in prevalence of overweight with age is more gradual in females than males (Figures 5a and 5d ), but the greatest rate of change in prevalence between 2003 and 2012 has occurred in the [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] year age groups in both genders. 
Obesity
Different from overweight, the prevalence of obesity has tracked closely between males and females from 2003 to 2012 (Figure 4b) .
A gradual increase in the prevalence of obesity has been observed, from 17.2% in males in 2003 to 21.6% in 2012, and 19.5% to 23.1% in females. An increase in obesity prevalence with age is also evident, with the highest prevalence observed in the 55-64 year age group for both males and females (Supplementary Table 2 , available online).
The results of the FDA show a clear peak in the rate of change in obesity for females in the 25-34 year age group (Figure 5b ), compared to a more rounded peak across the 25-34 and 35-44 year age groups for males ( Figure 5e ). The rate of increase in obesity prevalence slowed with age. Based on these trends, the forecast coefficients suggest a continuing increase in population prevalence of obesity through to 2019 (Figures 5c and  5f) . Overall, the forecast model suggests the prevalence of obesity in males is expected to 2%) . Generally, the increase in obesity is gradual over the forecast years for males and females (Figures 2e and 2f) . The greatest increase in the prevalence of obesity is expected for females aged 25-34 years where the prevalence could reach 33%. The greatest increase in males is in those aged in the mid-30s to mid-40s (Figure 3b) , where the prevalence of obesity may reach almost 35%.
Discussion
The obesity epidemic is considered one of the greatest public health challenges confronting Australia and other industrialised countries. [26] [27] [28] The rise in prevalence of obesity over the last decade presented in this paper supports national and international data. 1, 2, 7, 8 However, to our knowledge, this is the first application of FDA to estimate future increases in BMI and obesity. FDA is a novel, innovative trend forecasting tool which uses smoothing and noise reduction data techniques that should result in more accurate projections of obesity than alternative approaches, such as regression models. We suggest that without major intervention the average BMI of the Australian adult population will continue to increase (~0.5 kg/m 2 by 2019, but up to 1 kg/m 2 in some groups) and the prevalence of obesity could reach 33-34% in some sub-groups of the population. The estimates of the prevalence of overweight and obesity for 2019 were 67% (60% in females and 75% in males), 2% higher than previous projections. 1 This trajectory of predicted weight gain among adults, particularly in younger age groups, will have serious impacts on individuals' quality of life. The number of years lived with obesity has been shown to be associated with risk of cardiovascular disease related and all-cause mortality. 29 With more of the population becoming obese and at a younger age, the consequences of obesity will exert more pressure on over-stretched health care systems.
Action is needed to ensure individuals stay within their weight status category and avoid the upwards slide into the overweight or obese categories. Forecasting suggests that while overweight will plateau, overweight Figures 5a and 5d ), the first basis function (Figures 5b and 5e ) and the coefficient associated with the first basis function (Figures 5c and 5f ). 5a 5b 5c 5d 5e 5f as a precursor to obesity is still of concern, particularly for men where 45% are currently overweight. While this data are crosssectional in nature and do not track weight gain in individuals, the upward shift in BMI of the population towards obesity has also been shown in longitudinal studies. The AusDiab study recruited 11,247 Australian adults (aged 25+ years) in 1999-2000 and followed them over a 12-year period (~55% of sample participated in follow-up data collection). The annual incidence of overweight was 2.6% and the annual incidence of obesity was 1.3%. For those individuals who were normal or overweight at baseline, 28.4% had progressed to a higher BMI category during follow-up. The reverse was not common; that is few obese individuals moved to a lower BMI category at follow-up. 30 Increases in BMI and obesity prevalence over the adult years for women relate to the reproductive transitions -during pregnancy (aged in their 30s) and menopause years (aged in their 50s). 31 The rate of increase in obesity has been highest for women of mid-childbearing age 32 and, notably in our study, this increase occurred at a faster rate than men at this age; however, for men it stays elevated through their 30s and into their mid-40s. Longitudinal studies have also demonstrated that the rate of weight gain is highest amongst this age group of adults and declines with age. 30, 33 In the AusDiab study, the average weight gain over 12 years was 2.6 kg for all age groups; however, weight gain for those aged 25-34 years at baseline was 6.7 kg compared to 0.4 kg for those aged 55-64 years at baseline. 30 While our data is limited to the South Australian population, the Australian Longitudinal Study on Women's Health, a national population-based study, also shows the rate of increase in BMI is greatest for young women of childbearing age. 34 Excess weight gain during pregnancy and failure to return to pre-pregnancy weight within six months postpartum are predictors of long-term obesity 35, 36 and many women cite pregnancy as one of the life-course events associated with the advent of weight gain in adulthood. Our projections suggest that, in the future, Australian mothers will be starting their pregnancy journey from a heavier baseline, which will further exacerbate weight management at this life stage. Further to this, there is a link between maternal obesity and an increased risk of obesity in their children, meaning future generations will be at a greater risk of obesity. 37 The FDA approach can effectively model the age-related changes in BMI over time, and therefore allow predictions for specific age groups to be made. 11 The ability to identify sub-groups across the whole population at greatest risk of obesity over time allows primary and secondary interventions to be targeted to particular life stages.
Strengths and limitations
This is the first published application of FDA to forecast overweight and obesity in an Australian or international population. The approach of initially smoothing the data and then using the smoothed observations for modelling and prediction estimation is a major methodological improvement
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© 2015 Public Health Association of Australia to fit linear/non-linear trends of observed prevalence rates. A second strength of the FDA approach is the improved modelling of inconsistent increases in prevalence rates over time, and allows unstable trends and high variability of prevalence rates across ages to be captured in projections.
The key strength of the data used in this modelling is the standardised data collection method used across many years, and in a large representative sample. However, in population surveys a common limitation is the use of self-reported height and weight which are subject to misreporting, 38, 39 and using self-reported measurements could underestimate the prevalence of overweight and obesity by 5% or more in males and female adults. 40 Therefore, in the context of our results, it is likely that the estimates of BMI and weight status are a conservative estimate of obesity, and the future prevalence may be even greater than projected.
Our forecasting models have used data collected continuously over 10 years for South Australia, which is one jurisdiction, and accounts for 7.5% of the total Australian population. There are some differences in the demographic characteristics of South Australia compared to Australia more generally, mainly as a consequence of the slightly older population (median age 39 vs 37 years nationally), 13 which influence estimates of overweight and obesity slightly, but we believe the forecasting is valuable more broadly given the widespread nature of obesity. Further forecasting analysis will examine other demographic sub-groups, as the most disadvantaged groups have been identified to be at greater risk of overweight and obesity. 41, 42 Also, a random telephone survey approach was used to collect data for this study and has been used extensively in the past. The increasing community reliance on the mobile network is thought to not affect health estimates in telephone surveys; 43 however, this needs to be monitored to ensure telephone-surveyed samples continue to be representative of the wider community.
BMI, overweight and obesity may vary through changes in public health policy. The FDA forecasting did not take into account the impact of changes in public health policy within an obesogenic environment, especially at state level. Although observational errors have been reduced through smoothing technique in the case of changing rates over time, changes in public health policy may affect the accuracy of the model.
Further research and action
The worldwide obesity epidemic indicates that poor diet and lack of physical activity are replacing smoking as the key behavioural determinants of preventable disease. 2, 44 A vision for Australia to be the healthiest country by 2020 has been proposed, but progress on implementing the full scope of the recommendations to reduce obesity has been limited. 45 A comprehensive and integrated program of action to control population weight gain, at the level of the individual and environment, has been suggested, 46, 47 with strategies largely in line with the more recent nutrition and physical activity recommendations from the World Health Organization to prevent and manage non-communicable diseases that are major contributors to preventable mortality and morbidity. 28 Obesity needs to be at the forefront of all government agendas. Past trends and future projections in Australia would suggest a major investment or shake up in the approach is required to attenuate the anticipated increase in diseases associated with increases in overweight and obesity.
